CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports – Immuno-Oncology News
Immuno-Oncology News |
CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports
Immuno-Oncology News Immunotherapy using genetically modified immune T-cells (CAR-T) to specifically target the glioma-associated marker IL13Rα2 — a gene expression indicative of an aggressive brain tumor — was reported to be a successful treatment for recurrent … |
